Terns Pharmaceuticals, Inc.
TERN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $341,575 | $252,468 | $505,473 |
| - Cash | $150,698 | $145,966 | $139,023 | $161,439 |
| + Debt | $570 | $1,133 | $1,235 | $1,347 |
| Enterprise Value | – | $196,742 | $114,680 | $345,381 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$108 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$24,577 | -$23,921 | -$27,258 | -$25,735 |
| % Margin | – | – | – | – |
| Net Income | -$24,635 | -$24,093 | -$23,908 | -$21,799 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.27 | -0.26 | -0.26 | -0.24 |
| % Growth | -3.8% | 0% | -8.3% | – |
| Operating Cash Flow | -$19,773 | -$18,880 | -$24,446 | -$14,584 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$19,773 | -$18,880 | -$24,446 | -$14,584 |